Biosimilars Market Poised for Significant Growth The global biosimilars market is experiencing remarkable expansion, driven by the increasing demand for cost-effective biologic therapies and the rising prevalence of chronic diseases. Valued at approximately USD 21 Bn billion in 2022, the market is projected to reach USD 66.9 billion by 2029, exhibiting a robust Compound Annual...